期刊文献+

中药“通腑洁肠汤”对不全性肠梗阻结直肠癌术前肠道准备的效果观察 被引量:1

中药“通腑洁肠汤”对不全性肠梗阻结直肠癌术前肠道准备的效果观察
下载PDF
导出
摘要 目的:探讨中药"通腑洁肠汤"对结直肠癌患者术前肠道准备的安全性,有效性及其临床意义。方法:术前随机给予83例不全性肠梗阻的结直肠癌患者口服中药"通腑洁肠汤"或磷酸钠盐电解质液肠道准备,前者为中药组42例,后者为对照组41例。对比两者肠道清洁度,肠道准备过程中及术后并发症。结果:中药组肠道清洁程度达到优者(Ⅰ级)36例,良(Ⅱ级)4例,一般(Ⅲ级)1例,差(4级)1例,优良率达95.24%,对照组各级病例数分别为34例、3例、1例和3例,优良率为90.24%,两组优良率差异无统计学意义,P>0.05。两组肠道准备过程中并发完全性肠梗阻、肠穿孔、水电解质紊乱、术后并发吻合口漏、切口感染的病例数分别为0例、0例、0例、0例、1例和3例1例、0例、1例、2例。两组并发症发生率有显著差异,P<0.05.结论:中药"通腑洁肠汤"对不完全性肠梗阻的结直肠癌患者具有良好的肠道清洁作用,且并发症少,值得推广采用。 Objeelive: To explore the security, availability and significance of 'Tongfu Jiechang Soup' for bowel preparation in Colorectal Cancer patient. Method: 83 patients Colorectal Cancer patients accompany with partial ileus received 'Tongfu Jicchang Soup' or oral liquid of sodium phosphate ran- domly. Then the enteric cleaness and the complication during the intestinalpreparation and postoperation in the two groups were observed and com- pared. Results: InChinese drug group, 36 patients got them enteric cleaness perfect, 4 patients got them enteric cleaness fine, 1 patient got them enteric cleaness middling and 1 patient got them enteric mess. The fineness of Chinese drug group is 95.24%. In control group, 34 patients got them enteric cleaness perfect, 3 patients got them enteric cleaness fine, 1 patient got them enteric cleanessmiddling and 3 patient got them enteric mess. The fineness of control group is 90.24%. There is no difference between the two groups ( P 〉 0.05). In chinese drug group, only 1 patient got inci- sion infection. In control group, 3 patient got ileus, 1 patients got perforation, 1 patient got postoperative stomal leak, 2 patients got incision infec- tion. Conclusion: Chinese drug cleaning bowel of Coloreetal Cancer patient is good. A little complication will happen. It is worth to extend.
出处 《内蒙古中医药》 2013年第4期19-20,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 中药 结直肠癌 不全性肠梗阻 肠道准备 Chinese drug, Colorectal Cancer, partial ileus, Bowel Preparation
  • 相关文献

参考文献3

二级参考文献44

共引文献34

同被引文献17

  • 1Koukourakis GV,Sotiropoulou LA. Targeted therapy with bevacizumab for metastatic colorectal cancer[J]. Clin Transl Oncol,2011,13(10) :710-714.
  • 2Katsumoto Y, Aritake N, Endoh A, et al. Three cases of pa- tients in their eighties who receive danti-EGFR antibody mono-therapy as first-line treatment for metastatic col orectal cancer[J]. GanTo Kagaku Ryoho,2013,38(12):2244- 2246.
  • 3Spath-Schwalbe E, Lange C,Genvresse I, et al. Influence of am-ifostine on toxicity of CHOP in elderly patients with aggressivenon-Hodgkin's lymphoma-a phase 11 study [J].Anticancer Drugs, 2002, 13 (4) : 395-403.
  • 4Shimada K,Ajani JA.Adjuvant therapy for gastric carci- nomapatients in the past 15 years:A review of western and orientahrials[J]. Cancer, 2012,86(9) : 1657-1668.
  • 5Sandier A, Graham C, Baggstrom, et al. An openlabel muhicenter three-stage phase II study of s-1 in combi- nation with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer[J]. J Thorac 0ncol,2011,6(8) : 1400-1406.
  • 6Sanoff HK,Sargent DJ,Campbell ME,et al. Five-year data andprognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer[J]. J Clin Oncol, 2008,26 (35) : 5721-5727.
  • 7Tsai WS,Hsieh PS. Impact of chemotherapy-related prog- nostic factors onlong-term survival in patients with stage m colorectal cancer after curative resection[J]. Int J Clin Oncol, 2013,18(2) : 242-253.
  • 8Fleshman J,Sargent D J,Green E,et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial[J]. Ann Surg, 2007,246(4) : 655-664.
  • 9张振华,吴敬波.脂质体阿霉素热化疗对食管癌细胞的毒性实验研究[J].肿瘤防治研究,2011,38(7):736-739. 被引量:12
  • 10陈佳慧,王城,肖江卫,任明扬,唐锦,王崇树.中药“通腑洁肠汤”对老年不全性肠梗阻结直肠癌术前肠道准备的效果观察[J].结直肠肛门外科,2012,18(4):213-216. 被引量:5

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部